ICON 1: Physician Treatment Decisions and Patient-Reported Outcomes in Pediatric Refractory Immune Thrombocytopenia
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The main purpose of this research study is to learn more about how treatment decisions are made and how well treatments work in ITP.
Description
The purpose of this study is to model factors that determine physician treatment decisions in selecting specific second line agents in pediatric ITP; to assess patient reported outcomes with relation to specific second line pediatric ITP therapies; and to determine the comparative effectiveness of secondline ITP treatments in terms of bleeding and platelet counts.
Details
| Condition | Pediatric Refractory Immune Thrombocytopenia |
|---|---|
| Age | 1years - 18years |
| Clinical Study Identifier | TX6641 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.